Trends on the Role of PET in Drug Development
Philip H. Elsinga(University Medical Center Groningen), Rudi Dierckx(University Medical Center Groningen), Aren van Waarde(University Medical Center Groningen), Anne M. J. Paans(University Medical Center Groningen)
Cited by 18
Related Papers
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
|Molecular Neurobiology|2018|750
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
|Journal of Nuclear Medicine|2009|562
Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy
|Journal of Psychopharmacology|2017|279
The Use of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mrow><mml:mn mathvariant="bold">18</mml:mn></mml:mrow></mml:mrow></mml:math>F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
|Clinical and Developmental Immunology|2013|245
Added Value of <sup>99m</sup>Tc-HMPAO–Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis
|Journal of Nuclear Medicine|2012|221